Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to evaluate and compare in pregnant women with threatened miscarriage in the first trimester. The main questions it aims to answer are: What is the correlation between serum C reactive protein (CRP) levels and fetal ultrasound parameters in predicting threatened miscarriage? How accurate are serum C reactive protein (CRP) levels versus ultrasound in predicting pregnancy loss in threatened miscarriage? Participants will have blood tests to measure C reactive protein (CRP) levels and fetal ultrasound exams to assess parameters like crown-rump length. Researchers will compare serum C reactive protein (CRP) levels and fetal ultrasound findings to see if either or both can accurately predict pregnancy loss in women with first trimester threatened miscarriage.


Clinical Trial Description

This observational study will enroll 100 pregnant women, with 50 in the threatened miscarriage group and 50 healthy controls, to compare serum C reactive protein (CRP) levels and fetal ultrasound findings for predicting early pregnancy loss. Women presenting with first trimester bleeding and cramps concerning for threatened miscarriage will undergo blood testing to measure C reactive protein (CRP) levels and fetal ultrasound to assess parameters including crown-rump length, heartbeat, yolk sac size, and embryonic motion. The control group will consist of 50 low-risk pregnant women without threatened miscarriage matched for gestational age. Controls will undergo the same blood and ultrasound assessments. Researchers will compare serum C reactive protein (CRP) levels and ultrasound measurements between the threatened miscarriage and control groups. They will analyze which parameters differ significantly between groups and examine the predictive utility of C reactive protein (CRP) levels versus ultrasound for determining pregnancy viability. Key outcomes will include correlation of C reactive protein (CRP) with ultrasound parameters, and diagnostic accuracy of C reactive protein (CRP) levels versus ultrasound in predicting pregnancy loss in threatened first trimester miscarriages. This study aims to help optimize early pregnancy loss prediction and counseling for women with potential threatened miscarriage. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06011057
Study type Observational
Source Al-Azhar University
Contact
Status Completed
Phase
Start date July 1, 2022
Completion date October 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT02633878 - Chinese Herbal Medicine and Micronized Progesterone for Live Births in Threatened Miscarriage Phase 2
Completed NCT03309735 - Non-interventional Study of Therapy for Threatened Miscarriage N/A
Completed NCT03358940 - Assessment of Non-medical Use of Misoprostol in Case of Miscarriage or Threatened Miscarriage. N/A
Recruiting NCT02690129 - Vaginal Progesterone for Treatment of Threatened Miscarriage N/A